Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits.
Petraitis V, Petraitiene R, Groll AH, Roussillon K, Hemmings M, Lyman CA, Sein T, Bacher J, Bekersky I, Walsh TJ. Petraitis V, et al. Among authors: lyman ca. Antimicrob Agents Chemother. 2002 Jun;46(6):1857-69. doi: 10.1128/AAC.46.6.1857-1869.2002. Antimicrob Agents Chemother. 2002. PMID: 12019101 Free PMC article.
Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
Walsh TJ, Petraitis V, Petraitiene R, Field-Ridley A, Sutton D, Ghannoum M, Sein T, Schaufele R, Peter J, Bacher J, Casler H, Armstrong D, Espinel-Ingroff A, Rinaldi MG, Lyman CA. Walsh TJ, et al. Among authors: lyman ca. J Infect Dis. 2003 Jul 15;188(2):305-19. doi: 10.1086/377210. Epub 2003 Jul 9. J Infect Dis. 2003. PMID: 12854088
Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.
Petraitiene R, Petraitis V, Lyman CA, Groll AH, Mickiene D, Peter J, Bacher J, Roussillon K, Hemmings M, Armstrong D, Avila NA, Walsh TJ. Petraitiene R, et al. Among authors: lyman ca. Antimicrob Agents Chemother. 2004 Apr;48(4):1188-96. doi: 10.1128/AAC.48.4.1188-1196.2004. Antimicrob Agents Chemother. 2004. PMID: 15047519 Free PMC article.
Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy.
Hope WW, Kruhlak MJ, Lyman CA, Petraitiene R, Petraitis V, Francesconi A, Kasai M, Mickiene D, Sein T, Peter J, Kelaher AM, Hughes JE, Cotton MP, Cotten CJ, Bacher J, Tripathi S, Bermudez L, Maugel TK, Zerfas PM, Wingard JR, Drusano GL, Walsh TJ. Hope WW, et al. Among authors: lyman ca. J Infect Dis. 2007 Feb 1;195(3):455-66. doi: 10.1086/510535. Epub 2006 Dec 21. J Infect Dis. 2007. PMID: 17205486
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
Petraitis V, Petraitiene R, Groll AH, Sein T, Schaufele RL, Lyman CA, Francesconi A, Bacher J, Piscitelli SC, Walsh TJ. Petraitis V, et al. Among authors: lyman ca. Antimicrob Agents Chemother. 2001 Feb;45(2):471-9. doi: 10.1128/AAC.45.2.471-479.2001. Antimicrob Agents Chemother. 2001. PMID: 11158743 Free PMC article.
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling.
Groll AH, Mickiene D, Petraitiene R, Petraitis V, Lyman CA, Bacher JS, Piscitelli SC, Walsh TJ. Groll AH, et al. Among authors: lyman ca. Antimicrob Agents Chemother. 2001 Oct;45(10):2845-55. doi: 10.1128/AAC.45.10.2845-2855.2001. Antimicrob Agents Chemother. 2001. PMID: 11557479 Free PMC article.
55 results